Tert-butylhydroquinone reduces lipid accumulation in C57BL/6 mice with lower body weight gain

Arch Pharm Res. 2013 Jul;36(7):897-904. doi: 10.1007/s12272-013-0109-3. Epub 2013 Apr 16.

Abstract

tert-Butylhydroquinone (tBHQ) is a commonly used antioxidant additive that is approved for human use by both the Food and Agriculture Organization and the World Health Organization (FAO/WHO). In this study, we examined the effect of tBHQ on body weight gain and found that food supplementation with 0.001 % (w/w) tBHQ inhibited 61.4 % (P < 0.01) of body weight gain in high-fat diet (HFD)-induced C57BL/6 mice, and the oral administration of tBHQ (1.5 mg/kg) reduced 47.5 % (P < 0.05) of body weight gain in normal diet fed db/db mice. The HFD increased lipid deposit in adipocytes, but these were reduced significantly by tBHQ treatment in C57BL/6 mice. tBHQ supplementation significantly lowered the plasma triglyceride and total cholesterol, with reduced size of accumulated fat mass. The rate limiting enzyme of beta-oxidation (ACOX1) was significantly over-expressed in the liver with tBHQ treatment. These results indicate that tBHQ suppresses body weight gain in mice, possibly at least related to the up-regulation of ACOX1 gene expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / adverse effects
  • Antioxidants / pharmacology
  • Body Weight / drug effects*
  • Body Weight / physiology
  • Diet, High-Fat* / methods
  • Hydroquinones / adverse effects
  • Hydroquinones / pharmacology*
  • Lipid Metabolism / drug effects*
  • Lipid Metabolism / physiology
  • Liver Neoplasms / chemically induced
  • Liver Neoplasms / diagnosis
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Random Allocation
  • Weight Gain / drug effects*
  • Weight Gain / physiology

Substances

  • Antioxidants
  • Hydroquinones
  • 2-tert-butylhydroquinone